FindTrial
Sign In

4-dimensional computed tomography

PROCEDURE6 trials

Sponsors

M.D. Anderson Cancer Center, Virginia Commonwealth University, University of Nebraska

Conditions

Lung CancerMetastatic Malignant Neoplasm in the LiverMetastatic Malignant Neoplasm in the LungPancreatic AdenocarcinomaRecurrent Non-small Cell Lung CancerResectable Pancreatic CarcinomaStage I Pancreatic CancerStage IA Pancreatic Cancer

Phase 2

Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer
CompletedNCT01959672
University of NebraskaPancreatic Adenocarcinoma, Resectable Pancreatic Carcinoma, Stage IA Pancreatic Cancer +6
Start: 2013-09-06End: 2018-12-01Updated: 2023-10-10

Unknown Phase

4D PET/CT in Diagnosing Participants With Lung and Colorectal Cancer With Liver and Lung Metastasis
CompletedNCT00862680
M.D. Anderson Cancer CenterMetastatic Malignant Neoplasm in the Liver, Metastatic Malignant Neoplasm in the Lung, Stage IVA Colorectal Cancer AJCC v8 +6
Start: 2009-03-12End: 2019-04-28Updated: 2020-04-14
4D Image-guided Adaptive Radiotherapy for Lung Cancer: Patient Image Acquisition
CompletedNCT01018147
Virginia Commonwealth UniversityLung Cancer
Start: 2006-09-30End: 2015-10-31Updated: 2016-02-08
Prone Patient Positioning in Reducing Tumor Motion and Improving Breathing Reproduction in Patients With Lung Cancer Undergoing Radiation Therapy
TerminatedNCT01851161
Virginia Commonwealth UniversityLung Cancer
Start: 2010-05-31End: 2015-09-30Updated: 2015-09-18
CT in Diagnosing Patients With Lung Cancer
CompletedNCT01888510
Virginia Commonwealth UniversityLung Cancer
Start: 2013-05-31End: 2016-06-30Updated: 2016-07-07
Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer
WithdrawnNCT02059889
Virginia Commonwealth UniversityRecurrent Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer +2
Start: 2014-07-31End: 2016-12-31Updated: 2016-12-16

Related Papers

Disruption of FDPS/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and immunosuppressive signalling.
2021-12-2824 citations
Phase I/II Trial of Neoadjuvant Oregovomab-based Chemoimmunotherapy Followed by Stereotactic Body Radiotherapy and Nelfinavir For Locally Advanced Pancreatic Adenocarcinoma
American Journal of Clinical Oncology2019-09-1021 citations
A phase II study of neodjuvant chemoimmunotherapy followed by stereotactic radiotherapy/nelfinavir in patients with locally advanced CA125 expressing pancreatic adenocarcinoma.
Journal of Clinical Oncology2018-05-20